Antiviral therapy prevents recurrence of HCC, extends patients lives, researchers report
Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B. But now, researchers from the Division of Gastroenterology and Hepatology at Thomas Jefferson University are reporting that the antiviral therapy also prevents recurrence of HCC and extends patients’ lives.
Leave a Response
You must be logged in to post a comment.
